Somatic mutations in DNMT3A, TET2, and ASXL1 (referred to as “DTA” mutations) are commonly found in AML patients but are also seen in clinically asymptomatic individuals with increased prevalence with aging (27–30). The gene discussed is TET2; the disease is acute myeloid leukemia.